SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-170784
Filing Date
2017-05-15
Accepted
2017-05-15 17:02:16
Documents
70
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d352014d10q.htm 10-Q 442296
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d352014dex311.htm EX-31.1 6419
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER d352014dex312.htm EX-31.2 6449
4 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 d352014dex321.htm EX-32.1 2972
5 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 d352014dex322.htm EX-32.2 3012
  Complete submission text file 0001193125-17-170784.txt   3658919

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bdsi-20170331.xml EX-101.INS 565240
7 XBRL TAXONOMY EXTENSION SCHEMA bdsi-20170331.xsd EX-101.SCH 57184
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bdsi-20170331_cal.xml EX-101.CAL 68648
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bdsi-20170331_def.xml EX-101.DEF 185415
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdsi-20170331_lab.xml EX-101.LAB 409867
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdsi-20170331_pre.xml EX-101.PRE 304453
Mailing Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612
Business Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Filer) CIK: 0001103021 (see all company filings)

IRS No.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31361 | Film No.: 17845471
SIC: 2834 Pharmaceutical Preparations